Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST)

Share :
Published: 9 Oct 2012
Views: 6858
Dr Yves Menu – Saint Antoine Hospital, Paris, France

Dr Yves Menu talks to ecancer about the RECIST system for evaluating the effectiveness of treatments at the 2012 ESMO meeting in Vienna.

RECIST measures tumours morphologically and makes a follow up after treatment to determine efficacy. This is an international standard in treatment as it provides simple indicators that are universally understood.


Filming supported by Amgen